Search Results

联合检测LDHA和PD-L1在晚期胃癌PD-1 抑制剂疗效预测及预后评估中的价值.

• Authors : 左学良; 陈志强; 董润雨

Subjects: SURVIVAL analysis (Biometry); STOMACH cancer; RECEIVER operating characteristic curves

• Source: China Oncology; May2023, Vol. 33 Issue 5, p460-468, 9p

Record details

[Efficacy of lobaplatin plus S-1 and the predictive value of circulating tumor cell in patients with advanced gastric cancer].

• Authors : Feng Q; Department of Gastroenterology, Liaocheng People's Hospital, Liaocheng 252000, China.; Zhao JR

Subjects: Neoplastic Cells, Circulating*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Cyclobutanes/Cyclobutanes/Cyclobutanes/*administration & dosage

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 Sep 23; Vol. 40 (9), pp. 696-702.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[A safety analysis in patients treated with oxaliplatin plus S-1 as adjuvant therapy for gastric cancer].

• Authors : Zhou Y; Department of Medical Oncology, Chinese Academy of Medical Sciences, Beijing, China.; Huang J

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Organoplatinum Compounds/Organoplatinum Compounds/Organoplatinum Compounds/*administration & dosage

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2012 Nov; Vol. 34 (11), pp. 860-4.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Comparison between the effects of irinotecan or oxaliplatin combined with capecitabine in the treatment of advanced gastric cancer].

• Authors : Zhao WY; Department of Medical Oncology, Yijishan Hospital, Wannan Medical College, Anhui Wuhu 241000, China. ; Chen DY

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Camptothecin/Camptothecin/Camptothecin/*analogs & derivatives

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2011 Apr; Vol. 33 (4), pp. 295-8.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Oxaliplatin-based regimen for the treatment of advanced or metastatic gastric/esophagogastric junction cancer].

• Authors : Li J; Department of Gastrointestinal Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing 100142, China.; Lu M

Subjects: Esophagogastric Junction*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Folfox protocol

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2009 Dec; Vol. 31 (12), pp. 933-6.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].

• Authors : Lou F; Department of Oncology Center, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, SIR Run Run ShawInstitute of Clinical Medicine of Zhejiang University, Hangzhou 310016, China.; Zhu YH

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Signet Ring Cell/Carcinoma, Signet Ring Cell/Carcinoma, Signet Ring Cell/*drug therapy ELF protocol

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2009 Jan; Vol. 31 (1), pp. 75-8.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Clinical results of advanced gastric cancer patients treated with oxaliplatin-containing regimen].

• Authors : Zhang WM; The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, PR China. ; Xu GH

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Organoplatinum Compounds/Organoplatinum Compounds/Organoplatinum Compounds/*administration & dosage ; Stomach Neoplasms/Stomach Neoplasms/Stomach Neoplasms/*drug therapy

• Source: Ai zheng = Aizheng = Chinese journal of cancer [Ai Zheng] 2003 Dec; Vol. 22 (12), pp. 1346-8.Publisher: Zhongshan da xue zhong liu fang zhi zhong xin Country of Publication: China NLM ID: 9424852 Publication Model: Print Cited Medium: Print

Record details

影响Ⅲ 期食管癌术后患者预后的因素.

• Authors : 杨琼; 王玉祥; 何明

• Source: Chinese Journal of Oncology; 7/23/2016, Vol. 38 Issue 7, p530-537, 8p

Record details

中性粒细胞/淋巴细胞比率与转移性胃癌患者预后的关系.

• Authors : 李美; 赵峰; 俞婷

• Source: Tianjin Medical Journal; 2020, Vol. 48 Issue 11, p1079-1082, 4p

Record details

铂敏感复发性卵巢癌维持治疗药物的研究进展.

• Authors : 常鑫; 韩璐

• Source: Journal of International Obstetrics & Gynecology; Aug2022, Vol. 49 Issue 4, p382-387, 6p

Record details